Medical wearable patented.
Aseptika has won a European patent for its medical-grade wearable, BuddyWOTCH, for use by patients with severe cardiovascular and respirator) diseases (EU patent number 3197354, granted 3rd July 2019). Renfrew Group International contributed to the design and prototyping.
The product will continuously monitor, record and transmit the patient's physiological signs of blood oxygen, heart rate, breathing rate and temperature 24 hours a day, seven days a week. With its integrated nine-axis accelerometer, the device tracks, in real-time, the patient's physiological signs and how these change over time as the patient goes about daily life. As well as acting as an alert in case of medical emergencies, this information is used to continuously calculate the patient's overall health and to detect whether the wearer's health is getting better or is declining rapidly. The BuddyWOTCH can be used to test the patient in a GP clinic using the six-minute walk test something usually only performed in a laboratory setting during sessions at hospital outpatient clinic appointments.
The BuddyWOTCH platform connects directly to the company's Activ8rlives Cloud (or can be pointed to a partner's cloud system). Activ8rlives hosts portals for the patient, for family members caring for them and for clinicians, providing continuous monitoring and alerts as well as the index of tolerance to exercise.
The device will be CE-marked under the EU's Regulation on Medical Devices 2017/745 as a Class lib medical device, reflecting its role as a "life-critical medical monitor" replacing a bedside vital signs monitor for home-use, rather than a consumer-level accessory. This has been made possible through the development of Aseptika's MediOS, a real-time operating system designed to be a clinically-certifiable operating system for use in a range of medical monitors.
For more patent news, see also a new regular patents feature, pp26-7.